SENSITIZATION OF HUMAN BLADDER CANCER CELLS TO FAS-MEDIATED CYTOTOXICITY BY CIS-DIAMMINEDICHLOROPLATINUM (II)
- 1 August 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (2) , 561-570
- https://doi.org/10.1016/s0022-5347(01)62959-8
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Fas-mediated cytotoxicity by freshly isolated natural killer cells.The Journal of Experimental Medicine, 1995
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Overcoming tumor necrosis factor-α resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-α. Role of tumor necrosis factor-α mRNA down-regulation in tumor cell sensitizationCancer, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxinsCancer Immunology, Immunotherapy, 1992
- bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytesCell, 1991
- Evaluating and designing cancer chemotherapy treatment using mathematical modelsEuropean Journal of Cancer and Clinical Oncology, 1986
- The role of DNA repair in the recovery of human cells from cisplatin toxicityChemico-Biological Interactions, 1981
- Effects of cis-dichlorodiammine platinum (II) on DNA synthesis in kidney and other tissues of normal and tumour-bearing ratsPublished by Elsevier ,1976